CTE

8.77%

$1.24 cryosite limited

Yes wasn’t a newsletter after all. I’m surprised Andrew Kroger...

First 3 Last

Share
Profile

Follow
gmac55

1,046 Posts.

1

15/03/21

22:19

Post #: 51786214
Share

Originally posted by Medify: ↑

Cryosite seems to be attracting the serious attention of the institutional sector.

Today's substantial shareholder announcement reveals that Sydney-based DMX Asset Management has assembled a stake of 5.91%.

The group becomes the second-ranking shareholder after director Andrew Kroger who controls some 40%.

Third-ranker would appear to be BNP Paribas Nominees with 4.45%.

Given DMZ conducts focussed research and due diligence before investing, it seems likely the group would have had conversations with Kroger, with CTE chairman Bryan Dulhunty and with new CEO, John Hogg.

What is DMX's investment approach?

The group's website puts it this way:

We are focused on owning under-the-radar, inefficiently priced companies with low market capitalisations that have genuine potential to become larger companies.

Larger cap companies generally have greater profiles, more liquidity and attract higher multiples than smaller companies.

In our experience, small companies that are growing their profits, and particularly those that are growing their profits consistently, and rapidly, are well placed to become larger companies over time, as a higher earnings multiple is applied to a higher earnings base.

Accordingly, the half and full year profit reports are very important for us to benchmark how our portfolio companies are executing on their medium to long term growth plans.

DMX's on-market buying - apparently through Bell Potter - follows release of CTE's interim report.

With signs that DMX's buying operation may now be paused, the questions arises as to whether other instos will join the group and BNP Paribas as CTE backers.

Much will depend on how comfortable they are with terms of the proposed 10% shares buy-back to be launched by CTE on April 16.

Will CTE's brokers step into the market at 25c, 30c, 40c or 50c? We have a month to ponder possibilities.

Expand

Yes wasn’t a newsletter after all. I’m surprised Andrew Kroger didn’t purchase more. Initially thought it might have been him.

Be interesting to see what prices they will purchase for in buy back.

CTE Price at posting: 24.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

RCE

Recce's R327 found effective against E.coli during clinical trial

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

There are more pages in this discussion • 1 more message in this thread...

First 3 Last

Add CTE (ASX) to my watchlist

(20min delay)
Last $1.24		Change 0.100(8.77%)		Mkt cap ! $60.52M

Open	High	Low	Value	Volume
$1.20	$1.24	$1.20	$20.39K	16.87K

Buyers (Bids)

No.	Vol.	Price($)
1	3420	$1.14

Sellers (Offers)

Price($)	Vol.	No.
$1.24	9580	1

View Market Depth

No.	Vol.	Price($)
1	3420	1.140
1	2000	1.030
1	22000	0.980
2	1270	0.810
1	10000	0.795

Price($)	Vol.	No.
1.240	9580	1
1.250	54000	2
1.300	25000	1
1.350	25000	1
1.500	50	1

Last trade - 14.25pm 28/06/2024 (20 minute delay)

CTE (ASX) Chart

Yes wasn’t a newsletter after all. I’m surprised Andrew Kroger...

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes wasn’t a newsletter after all. I’m surprised Andrew Kroger...

Top Stories

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News